New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use; D001777:Blood Coagulation / Q000502:physiology*; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000201:enzymology; D001779:Blood Coagulation Factors / Q000378:metabolism; D025901:Carboxypeptidase B2 / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D004195:Disease Models, Animal; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D010940:Plant Proteins / Q000627:therapeutic use; D011480:Protease Inhibitors; D017434:Protein Structure, Tertiary; D011817:Rabbits; D013927:Thrombosis / Q000188:drug therapy / Q000201:enzymology
D000906:Antibodies; D001779:Blood Coagulation Factors; D010940:Plant Proteins; D011480:Protease Inhibitors; D005337:Fibrin; D025901:Carboxypeptidase B2